Marshall Wace’s Ingles Markets IMKTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.81M Buy
+31,298
New +$2.54M ﹤0.01% 1598
2023
Q4
Sell
-45,968
Closed -$3.46M 2368
2023
Q3
$3.46M Buy
45,968
+28,216
+159% +$2.27M 0.01% 1002
2023
Q2
$1.47M Buy
17,752
+5,752
+48% +$495K ﹤0.01% 1554
2023
Q1
$1.06M Hold
12,000
﹤0.01% 1776
2022
Q4
$1.16M Sell
12,000
-9,895
-45% -$929K ﹤0.01% 2022
2022
Q3
$1.74M Buy
+21,895
New +$1.99M ﹤0.01% 2102
2022
Q2
Sell
-80,561
Closed -$7.17M 3630
2022
Q1
$7.17M Buy
80,561
+17,794
+28% +$1.51M 0.01% 1120
2021
Q4
$5.42M Buy
+62,767
New +$4.79M 0.01% 1294
2021
Q1
Sell
-61,087
Closed -$2.61M 2652
2020
Q4
$2.61M Sell
61,087
-7,120
-10% -$275K 0.01% 842
2020
Q3
$2.6M Buy
68,207
+22,184
+48% +$893K 0.02% 736
2020
Q2
$1.98M Buy
+46,023
New +$1.87M 0.01% 796
2019
Q1
Sell
-3,892
Closed -$106K 1878
2018
Q4
$106K Buy
+3,892
New +$120K ﹤0.01% 1358

Other funds holding IMKTA

Marshall Wace's IMKTA Position: Q1 2026 in Review

Marshall Wace opened a new position in Ingles Markets (IMKTA) in Q1 2026: 31,298 shares worth $2.81M. The stake represents ﹤0.01% of the portfolio and ranks #1598 among its holdings. This is a return to the name: Marshall Wace previously reported a position in IMKTA as recently as Q3 2023.

Marshall Wace first reported a position in IMKTA in Q4 2018 and has held it in 12 quarters since. The position peaked at $7.17M in Q1 2022. 232 funds tracked by Wall St. Rank hold IMKTA as of Q1 2026.

  • Marshall Wace held 31,298 shares of Ingles Markets worth $2.81M as of Q1 2026.
  • Ingles Markets was a new Marshall Wace position in Q1 2026.
  • Ingles Markets made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1598 holding.
  • Marshall Wace first reported a position in Ingles Markets in Q4 2018 and has held it in 12 quarters since.
  • Marshall Wace's Ingles Markets position peaked at $7.17M in Q1 2022.
  • 232 funds tracked by Wall St. Rank held Ingles Markets as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.